Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Schizophrenia

  Free Subscription


15.05.2017

1 Am J Psychiatry
1 Biol Psychiatry
1 Br J Psychiatry
1 Compr Psychiatry
1 J Neuropsychol
2 Mol Psychiatry
6 Psychiatry Res
1 Psychol Med
1 Psychophysiology
10 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Psychiatry

  1. GOFF DC, Falkai P, Fleischhacker WW, Girgis RR, et al
    The Long-Term Effects of Antipsychotic Medication on Clinical Course in Schizophrenia.
    Am J Psychiatry. 2017 May 5:appiajp201716091016.
    PubMed     Text format     Abstract available


    Biol Psychiatry

  2. ARION D, Huo Z, Enwright JF, Corradi JP, et al
    Transcriptome Alterations in Prefrontal Pyramidal Cells Distinguish Schizophrenia From Bipolar and Major Depressive Disorders.
    Biol Psychiatry. 2017 Apr 4. pii: S0006-3223(17)31442.
    PubMed     Text format     Abstract available


    Br J Psychiatry

  3. FALKENBERG I, Benetti S, Raffin M, Wuyts P, et al
    Clinical utility of magnetic resonance imaging in first-episode psychosis.
    Br J Psychiatry. 2017 May 4. pii: bjp.bp.116.195834.
    PubMed     Text format     Abstract available


    Compr Psychiatry

  4. PENG R, Li Y
    Association among serum cortisol, dehydroepiandrosterone-sulfate levels and psychiatric symptoms in men with chronic schizophrenia.
    Compr Psychiatry. 2017;76:113-118.
    PubMed     Text format     Abstract available


    J Neuropsychol

  5. ETTINGER U, Aichert DS, Wostmann N, Dehning S, et al
    Response inhibition and interference control: Effects of schizophrenia, genetic risk, and schizotypy.
    J Neuropsychol. 2017 May 8. doi: 10.1111/jnp.12126.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  6. TAO R, Davis KN, Li C, Shin JH, et al
    GAD1 alternative transcripts and DNA methylation in human prefrontal cortex and hippocampus in brain development, schizophrenia.
    Mol Psychiatry. 2017 May 9. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available

  7. BIRNBAUM R, Jaffe AE, Chen Q, Shin JH, et al
    Investigating the neuroimmunogenic architecture of schizophrenia.
    Mol Psychiatry. 2017 May 9. doi: 10.1038/mp.2017.
    PubMed     Text format     Abstract available


    Psychiatry Res

  8. TERACHI S, Yamada T, Pu S, Yokoyama K, et al
    Comparison of neurocognitive function in major depressive disorder, bipolar disorder, and schizophrenia in later life: A cross-sectional study of euthymic or remitted, non-demented patients using the Japanese version of the Brief Assessment of Cogniti
    Psychiatry Res. 2017;254:205-210.
    PubMed     Text format     Abstract available

  9. FOND G, Godin O, Boyer L, Llorca PM, et al
    Advanced paternal age is associated with earlier schizophrenia onset in offspring. Results from the national multicentric FACE-SZ cohort.
    Psychiatry Res. 2017;254:218-223.
    PubMed     Text format     Abstract available

  10. ARMANDO M, Lin A, Pontillo M, Vicari S, et al
    Prevalence and treatment of psychiatric disorders other than psychosis in children and adolescents with 22q11DS: Examining associations with social and role functioning.
    Psychiatry Res. 2017;254:238-243.
    PubMed     Text format     Abstract available

  11. ISHIWATA S, Hattori K, Sasayama D, Teraishi T, et al
    Plasma and cerebrospinal fluid G72 protein levels in schizophrenia and major depressive disorder.
    Psychiatry Res. 2017;254:244-250.
    PubMed     Text format     Abstract available

  12. GALLETTI C, Paolini E, Tortorella A, Compton MT, et al
    Auditory and non-auditory hallucinations in first-episode psychosis: Differential associations with diverse clinical features.
    Psychiatry Res. 2017;254:268-274.
    PubMed     Text format     Abstract available

  13. BOUAZIZ N, Moulier V, Lettelier-Galle T, Osmond I, et al
    Impact of reward on pain threshold and tolerance to experimental pain (Cold Pressor Task) in healthy subjects and patients with schizophrenia.
    Psychiatry Res. 2017;254:275-278.
    PubMed     Text format    


    Psychol Med

  14. MORITZ S, Klein JP, Desler T, Lill H, et al
    Neurocognitive deficits in schizophrenia. Are we making mountains out of molehills?
    Psychol Med. 2017 May 9:1-11. doi: 10.1017/S0033291717000939.
    PubMed     Text format     Abstract available


    Psychophysiology

  15. PINHEIRO AP, Rezaii N, Rauber A, Nestor PG, et al
    Emotional self-other voice processing in schizophrenia and its relationship with hallucinations: ERP evidence.
    Psychophysiology. 2017 May 5. doi: 10.1111/psyp.12880.
    PubMed     Text format     Abstract available


    Schizophr Res

  16. LIU Y, Zhang Y, Lv L, Wu R, et al
    Abnormal neural activity as a potential biomarker for drug-naive first-episode adolescent-onset schizophrenia with coherence regional homogeneity and support vector machine analyses.
    Schizophr Res. 2017 May 2. pii: S0920-9964(17)30215.
    PubMed     Text format     Abstract available

  17. KUNUTSOR SK, Laukkanen T, Laukkanen JA
    Cardiorespiratory fitness is associated with reduced risk of future psychosis: A long-term prospective cohort study.
    Schizophr Res. 2017 May 2. pii: S0920-9964(17)30249.
    PubMed     Text format    

  18. CAROL EE, Mittal VA
    Corrigendum to "self-reported cannabis use is inconsistent with the results from drug-screening in youth at ultra high-risk for psychosis in Colorado" [Schizophr. Res. 157 (0) (August 2014) 317-318].
    Schizophr Res. 2017 May 2. pii: S0920-9964(17)30248.
    PubMed     Text format    

  19. KASKIE RE, Ferrarelli F
    Investigating the neurobiology of schizophrenia and other major psychiatric disorders with Transcranial Magnetic Stimulation.
    Schizophr Res. 2017 May 3. pii: S0920-9964(17)30254.
    PubMed     Text format     Abstract available

  20. CHIAPPELLI J, Chen S, Hackman A, Elliot Hong L, et al
    Evidence for differential opioid use disorder in schizophrenia in an addiction treatment population.
    Schizophr Res. 2017 May 6. pii: S0920-9964(17)30263.
    PubMed     Text format     Abstract available

  21. XIAO X, Yu H, Li J, Wang L, et al
    Further evidence for the association between LRP8 and schizophrenia.
    Schizophr Res. 2017 May 8. pii: S0920-9964(17)30262.
    PubMed     Text format     Abstract available

  22. LEE BS, McIntyre RS, Gentle JE, Park NS, et al
    A computational algorithm for personalized medicine in schizophrenia.
    Schizophr Res. 2017 May 8. pii: S0920-9964(17)30260.
    PubMed     Text format     Abstract available

  23. ROSSI A, Amore M, Galderisi S, Rocca P, et al
    The complex relationship between self-reported 'personal recovery' and clinical recovery in schizophrenia.
    Schizophr Res. 2017 May 8. pii: S0920-9964(17)30247.
    PubMed     Text format     Abstract available

  24. MARTINELLI C, Rigoli F, Averbeck B, Shergill SS, et al
    The value of novelty in schizophrenia.
    Schizophr Res. 2017 May 8. pii: S0920-9964(17)30266.
    PubMed     Text format     Abstract available

  25. PANDEY GN, Rizavi HS, Zhang H, Ren X, et al
    Abnormal gene and protein expression of inflammatory cytokines in the postmortem brain of schizophrenia patients.
    Schizophr Res. 2017 May 2. pii: S0920-9964(17)30252.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: